N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide

C25H33N3O3S — CID 169296610

IUPACN-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide
SMILESCS(=O)(=O)NC1CCCN2C(=O)NCCCCCc3ccccc3-c3cccc(c3)CC12
InChIInChI=1S/C25H33N3O3S/c1-32(30,31)27-23-14-8-16-28-24(23)18-19-9-7-12-21(17-19)22-13-5-4-11-20(22)10-3-2-6-15-26-25(28)29/h4-5,7,9,11-13,17,23-24,27H,2-3,6,8,10,14-16,18H2,1H3,(H,26,29)
InChIKeyZIEOBIMQRCOLJU-UHFFFAOYSA-N
MW455.62 g/mol
LogP3.71
Rot. Bonds2

About N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide

N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide (PubChem CID 169296610) has the molecular formula C25H33N3O3S and a molecular weight of 455.62 g/mol. Its IUPAC name is N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide.

Molecular Properties

Compound NameN-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide
PubChem CID169296610
Molecular FormulaC25H33N3O3S
Molecular Weight455.62 g/mol
Exact Mass455.22
IUPAC NameN-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide
SMILESCS(=O)(=O)NC1CCCN2C(=O)NCCCCCc3ccccc3-c3cccc(c3)CC12
InChIInChI=1S/C25H33N3O3S/c1-32(30,31)27-23-14-8-16-28-24(23)18-19-9-7-12-21(17-19)22-13-5-4-11-20(22)10-3-2-6-15-26-25(28)29/h4-5,7,9,11-13,17,23-24,27H,2-3,6,8,10,14-16,18H2,1H3,(H,26,29)
InChIKeyZIEOBIMQRCOLJU-UHFFFAOYSA-N
XLogP3.71
TPSA78.51 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds2
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500455.62
LogP ≤ 53.71
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Analyze N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide?
The IUPAC name of N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide (CID 169296610) is N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide.
What is the SMILES notation for N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide?
The canonical SMILES for N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide is CS(=O)(=O)NC1CCCN2C(=O)NCCCCCc3ccccc3-c3cccc(c3)CC12.
What is the InChIKey of N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide?
The InChIKey is ZIEOBIMQRCOLJU-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H33N3O3S/c1-32(30,31)27-23-14-8-16-28-24(23)18-19-9-7-12-21(17-19)22-13-5-4-11-20(22)10-3-2-6-15-26-25(28)29/h4-5,7,9,11-13,17,23-24,27H,2-3,6,8,10,14-16,18H2,1H3,(H,26,29).
What are the key properties of N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide?
N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide has a molecular weight of 455.62 g/mol, XLogP of 3.71, 2 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-(14-oxo-13,15-diazatetracyclo[20.3.1.02,7.015,20]hexacosa-1(25),2,4,6,22(26),23-hexaen-19-yl)methanesulfonamide is sourced from PubChem (CID 169296610), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).